title: Imatinib mesylate induced erythroderma.
authors.forename: Swapnil A
authors.initials: SA
authors.lastname: Sanghavi
authors.forename: Atul M
authors.initials: AM
authors.lastname: Dongre
authors.forename: Uday S
authors.initials: US
authors.lastname: Khopkar
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate